Peter Samuel Wulff
Direktor/Vorstandsmitglied bei Sementis Ltd.
Profil
Peter Samuel Wulff was the founder of Bavarian Nordic A, founded in 1992, where he held the title of President & Chief Executive Officer.
He is also the founder of Sentinext Therapeutics Sdn.
Bhd., founded in 2009, where he held the title of Chief Executive Officer from 2010 to 2012.
Additionally, he is the founder of iSD Immunotech ApS, founded in 2007, where he held the title of Chairman from 2007 to 2015.
Mr. Wulff's current job is as a Director at Sementis Ltd.
Mr. Wulff's former jobs include Chairman at Inagen ApS, Director-Patents & Licensing at NTG Nordic Transport Group A from 1989 to 1997, Director-Patents & Licensing at Ferrosan ApS from 1987 to 1989, Director at MedArt A, Director at Dansk Biotek, and Director at Spago Nanomedical AB.
Mr. Wulff received his undergraduate degree in 1979 and his graduate degree in 1980 from the University of Copenhagen.
Mr. Wulff is also the founder of IMSK SE.
Aktive Positionen von Peter Samuel Wulff
| Unternehmen | Position | Beginn |
|---|---|---|
Sementis Ltd.
 Sementis Ltd. BiotechnologyHealth Technology Sementis Ltd. is an Australian private company that develops next-generation vaccine viral-vector software platform. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Peter Samuel Wulff
| Unternehmen | Position | Ende |
|---|---|---|
iSD Immunotech ApS
 iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark. | Gründer | 14.07.2015 |
| BAVARIAN NORDIC A/S | Vorstandsvorsitzender | 29.04.2007 |
| NTG NORDIC TRANSPORT GROUP A/S | Corporate Officer/Principal | 01.01.1997 |
Ferrosan ApS
 Ferrosan ApS Pharmaceuticals: OtherHealth Technology Ferrosan ApS manufactures and sells pharmaceutical products. Its products include herbal medicine, natural remedies, food supplements, and medical devices. The company was founded by Niels Jacob Herman Weitzmann in 1920 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | 01.01.1989 |
| SPAGO NANOMEDICAL AB | Direktor/Vorstandsmitglied | - |
Ausbildung von Peter Samuel Wulff
| University of Copenhagen | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| BAVARIAN NORDIC A/S | Health Technology |
| SPAGO NANOMEDICAL AB | Health Technology |
| Private Unternehmen | 8 |
|---|---|
IMSK SE
 IMSK SE Marine ShippingTransportation IMSK SE engages in the provision of marine transportation services and maritime solutions. It also provides logistics solutions for the regional distribution of liquefied gases. The company was founded on November 12, 1996 and is headquartered in Oslo, Norway. | Transportation |
Ferrosan ApS
Ferrosan ApS Pharmaceuticals: OtherHealth Technology Ferrosan ApS manufactures and sells pharmaceutical products. Its products include herbal medicine, natural remedies, food supplements, and medical devices. The company was founded by Niels Jacob Herman Weitzmann in 1920 and is headquartered in Ballerup, Denmark. | Health Technology |
MedArt A/S
 MedArt A/S Medical SpecialtiesHealth Technology MedArt A/S aim to be your preferred partner within laser based treatments for surgical and aesthetic applications. More than 25 years of experience in the manufacturing of super compact, high performance diode and C02 lasers combined with scanning technology have provided doctors and clinics world-wide with high-performance equipment for strong patient satisfaction. Their unique combination of clinical understanding and proprietary technology has formed the background of their company and the MedArt® brand-medical art based on scientific research. | Health Technology |
Inagen ApS
 Inagen ApS Miscellaneous Commercial ServicesCommercial Services Inagen ApS is a holding company that develops novel biopharmaceuticals for anti-viral treatment opportunities. Its primary candidate is treatment for Cytomegalovirus (CMV). The technology utilizes a "self targeting capability", which takes place in the natural defense mechanism of the specific disease, to target and kill infected cells. Its platform technology can be utilized to target numerous infectious diseases. The company was founded by Thomas Nitschke Kledal l in 2007 and is headquartered in Lyngby, Denmark. | Commercial Services |
Dansk Biotek
 Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark. | Commercial Services |
Sentinext Therapeutics Sdn. Bhd.
 Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Health Technology |
iSD Immunotech ApS
iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark. | Health Technology |
Sementis Ltd.
Sementis Ltd. BiotechnologyHealth Technology Sementis Ltd. is an Australian private company that develops next-generation vaccine viral-vector software platform. | Health Technology |
